inclusion criteria for natalee trial - evaluating importance of ajuvant ribociclib #oncology #cancer
Published 10 months ago • 163 plays • Length 0:38Download video MP4
Download video MP3
Similar videos
-
21:29
breast cancer asco 2023 highlights - oncbrothers (rohit and rahul gosain) with dr. stephanie graff
-
2:23
natalee: ribociclib nsai as adjuvant treatment in patients with hr /her2− early breast cancer
-
14:04
her2 positive breast cancer algorithm - oncbrothers (rohit & rahul gosain) w/ dr. erika hamilton
-
1:48
natalee and monarche: ribociclib and abemaciclib in hr /her2- breast cancer
-
8:30
advances in early-stage breast cancer treatment: a recap of the natalee trial
-
53:17
patients with high risk features | 2023 best of breast conference
-
0:59
the expert clinical trial -breast cancer trials
-
30:40
prediction of response to anthracycline-based chemotherapy in early breast cancer
-
1:33
role & evaluation of pathologic response in early breast cancer specimens after neoadjuvant therapy
-
2:15
dr. boughey discusses the z11 trial in breast cancer
-
52:05
heritage video series: hematology/oncology | cincinnati children's
-
3:43
diversity and inclusion in clinical trials | stanford cancer institute
-
5:24
the extenet trial
-
2:20
defining, estimating, and communicating overdiagnosis in cancer screening
-
1:10:05
antibodies, genome stability, and cancer
-
1:33
the hera breast cancer clinical trial - breast cancer trials
-
9:03
sequencing therapies for differentiated thyroid cancer
-
1:30
utilizing genomic assays for decision making in early stage breast cancer
-
1:08:58
nadya tarasova - dissecting cancer signaling pathways with chemical scalpels